| 翻訳と辞書 |
| Study of Tamoxifen and Raloxifene ： ウィキペディア英語版 |
Study of Tamoxifen and Raloxifene
The Study of Tamoxifen and Raloxifene (STAR) is a clinical trial designed determine how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in women who are at increased risk of the disease.〔(【引用サイトリンク】 publisher=Weill Cornell Medical College )〕
==Research==
One of the largest breast cancer prevention studies ever,〔("Osteoporosis drug equals tamoxifen in preventing breast cancer" ), ''Pittsburgh Post-Gazette'', April 18, 2006〕 it included 22,000 women in 400 medical centers in the United States and Canada.〔("Drug Slashes Breast Cancer Risk, Study Shows" ), ''New York Times'', June 16, 1999〕〔(【引用サイトリンク】 title=What is the Study of Tamoxifen and Raloxifene Breast Cancer Prevention Trial? )〕〔(【引用サイトリンク】 publisher=Columbia St. Mary's )〕
The study concluded that raloxifene caused fewer side-effects and less endometrial cancer than tamoxifen.〔(【引用サイトリンク】 publisher=American Association for Cancer Research )〕〔("Raloxifene or tamoxifen: Which is the right drug for you?" ), USA Today, April 17, 2006〕 Raloxifene was found to be more effective at preventing noninvasive breast cancer but less effective at preventing invasive breast cancer.〔("Raloxifene, Tamoxifen Both Guard Against Breast Cancer" ), Business Week, April 19, 2010〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Study of Tamoxifen and Raloxifene」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|